We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$165M
AUM Growth
+$994K
Cap. Flow
+$1.37M
Cap. Flow %
0.83%
Top 10 Hldgs %
38.18%
Holding
544
New
44
Increased
65
Reduced
121
Closed
59

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$724K
2
GVI icon
iShares Intermediate Government/Credit Bond ETF
GVI
+$698K
3
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$475K
4
TSLA icon
Tesla
TSLA
+$398K
5
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$351K

Top Sells

Rank Stock Value
1
SCHP icon
Schwab US TIPS ETF
SCHP
+$556K
2
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$531K
3
HOOD icon
Robinhood
HOOD
+$345K
4
LLY icon
Eli Lilly
LLY
+$341K
5
CBOE icon
Cboe Global Markets
CBOE
+$299K

Sector Composition

Rank Sector Weight
1 Technology 6.4%
2 Financials 3.15%
3 Consumer Discretionary 2.92%
4 Communication Services 2.86%
5 Healthcare 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLYA
526
DELISTED
Playa Hotels & Resorts
PLYA
– –
-382
Closed -$2.96K
QSR icon
527
Restaurant Brands International
QSR
$25.6B
– –
-3,062
Closed -$221K
REYN icon
528
Reynolds Consumer Products
REYN
$5.51B
– –
-2,165
Closed -$67.3K
RLAY icon
529
Relay Therapeutics
RLAY
$4.37B
– –
-543
Closed -$3.84K
RXST icon
530
RxSight
RXST
$289M
– –
-8
Closed -$395
SGRY icon
531
Surgery Partners
SGRY
$2B
– –
-172
Closed -$5.54K
SHW icon
532
Sherwin-Williams
SHW
$88.4B
– –
-11
Closed -$4.2K
STZ icon
533
Constellation Brands
STZ
$22.8B
– –
-445
Closed -$115K
TGT icon
534
Target
TGT
$69.2B
– –
-10
Closed -$1.56K
TSVT
535
DELISTED
2seventy bio
TSVT
– –
-86
Closed -$406
VITL icon
536
Vital Farms
VITL
$504M
– –
-94
Closed -$3.3K
WING icon
537
Wingstop
WING
$3.06B
– –
-191
Closed -$79.5K
XYL icon
538
Xylem
XYL
$28.7B
– –
-30
Closed -$4.05K
YOU icon
539
Clear Secure
YOU
$4.98B
– –
-187
Closed -$6.2K
ZTS icon
540
Zoetis
ZTS
$31B
– –
-14
Closed -$2.73K
ACCD
541
DELISTED
Accolade Inc
ACCD
– –
-916
Closed -$3.53K
ML
542
DELISTED
MoneyLion Inc.
ML
– –
-5
Closed -$208
18 19 20 21
22

Similar funds

TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
IH
IES Holdings Houston, Texas $214M AUM
SIA
Serenity Investment Advisors Chicago, Illinois $214M AUM
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
PFA
Pinnacle Family Advisors Springfield, Missouri $213M AUM 24.93% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
CHA
Cooper/Haims Advisors Victor, New York $212M AUM 12.19% 1-Year Est. Return

C.M. Bidwell & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, C.M. Bidwell & Associates held 544 positions worth $165M, up 0.61% from $164M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

C.M. Bidwell & Associates's Q4 2024 filing shows 44 new, 65 increased, 121 reduced and 59 closed positions. Its largest new stake was Gilead Sciences: 3,801 shares worth $351K. The largest sale was Schwab US TIPS ETF, an estimated $556K.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • C.M. Bidwell & Associates's largest Q4 2024 buy was Gilead Sciences: 3,801 shares worth $351K.
  • C.M. Bidwell & Associates added most to Vanguard Short-Term Bond ETF in Q4 2024, an estimated $724K increase.
  • C.M. Bidwell & Associates's biggest Q4 2024 reduction was Schwab US TIPS ETF, cutting an estimated $556K.
  • C.M. Bidwell & Associates fully exited Eli Lilly in Q4 2024, selling an estimated $341K.
  • C.M. Bidwell & Associates's ten largest holdings make up 38% of its $165M portfolio in Q4 2024.
  • C.M. Bidwell & Associates opened 44 new positions and closed 59 in Q4 2024.
  • C.M. Bidwell & Associates's portfolio value rose 0.61% quarter-over-quarter to $165M.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.